Literature DB >> 30470403

Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas.

Anja Smits1, Asgeir S Jakola2.   

Abstract

Diffuse low-grade gliomas (DLGGs) are primary brain tumors characterized by slow growth but extensive infiltration into the surrounding brain. Patients are typically 30 to 40 years at disease onset and present with focal or focal to bilateral tonic-clonic seizures. The tumor will transform into a malignant glioma and eventually lead to death, but after varying lengths of time. The specific features of DLGG impose a major challenge to decide optimal treatment strategies and timing of treatment, while maintaining patients' quality of life. We discuss the clinical challenges at disease onset with regard to the natural history and long-term prognosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diffuse low-grade gliomas; Natural history; Prognosis; Symptoms

Mesh:

Year:  2018        PMID: 30470403     DOI: 10.1016/j.nec.2018.08.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  8 in total

1.  Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.

Authors:  Alexandre Roux; Arnault Tauziede-Espariat; Marc Zanello; Sophie Peeters; Gilles Zah-Bi; Eduardo Parraga; Myriam Edjlali; Emmanuèle Lechapt; Natalia Shor; Luisa Bellu; Giulia Berzero; Didier Dormont; Edouard Dezamis; Fabrice Chretien; Catherine Oppenheim; Marc Sanson; Pascale Varlet; Laurent Capelle; Frédéric Dhermain; Johan Pallud
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

2.  Development and validation of an MRI-based nomogram for the preoperative prediction of tumor mutational burden in lower-grade gliomas.

Authors:  En-Tao Liu; Shuqin Zhou; Yingwen Li; Siwei Zhang; Zelan Ma; Junbiao Guo; Lei Guo; Yue Zhang; Quanlai Guo; Li Xu
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 3.  The need to consider return to work as a main outcome in patients undergoing surgery for diffuse low-grade glioma: a systematic review.

Authors:  Juan Silvestre G Pascual; Hugues Duffau
Journal:  Acta Neurochir (Wien)       Date:  2022-08-09       Impact factor: 2.816

Review 4.  Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications.

Authors:  Valeria Internò; Giacomo Triggiano; Pierluigi De Santis; Luigia Stefania Stucci; Marco Tucci; Camillo Porta
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

Review 5.  The Concept of «Peritumoral Zone» in Diffuse Low-Grade Gliomas: Oncological and Functional Implications for a Connectome-Guided Therapeutic Attitude.

Authors:  Melissa Silva; Catalina Vivancos; Hugues Duffau
Journal:  Brain Sci       Date:  2022-04-15

6.  Risk factors for early progression of diffuse low-grade glioma in adults.

Authors:  Long Wang; Xuegang Li; Tunan Chen; Chao Zhang; Jiantao Shi; Hua Feng; Fei Li
Journal:  Chin Neurosurg J       Date:  2022-10-01

7.  Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study.

Authors:  Isabelle Rydén; Erik Thurin; Louise Carstam; Anja Smits; Sasha Gulati; Roger Henriksson; Øyvind Salvesen; Asgeir Store Jakola
Journal:  BMC Cancer       Date:  2021-03-08       Impact factor: 4.638

8.  Return to work following diagnosis of low-grade glioma: A nationwide matched cohort study.

Authors:  Isabelle Rydén; Louise Carstam; Sasha Gulati; Anja Smits; Katharina S Sunnerhagen; Per Hellström; Roger Henriksson; Jiri Bartek; Øyvind Salvesen; Asgeir Store Jakola
Journal:  Neurology       Date:  2020-06-15       Impact factor: 11.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.